Cell to cell signaling indicates the transfer of relevant information from one cell to another. Cells signal either by direct contact or by releasing certain substances that are taken up by other cells. Cell signaling is when cells communicate with other cells within their body or with the external environment, thereby allowing growth, development, and immunity. It is a process that transfers the specific information from the cell surface to the cytosol and ultimately to the nucleus, leading to the changes in gene expression. Cell signaling is used to study the cell pathways in drug discovery development and therapeutics.
The global cell signaling market size was valued at USD 4,566 million in 2019 and projected to reach USD 5,956 million by 2027, growing at a CAGR of 7.2% during the forecast period, 2020-2027. The significant factors are the growing demand for cell signaling is due to the rising prevalence of chronic diseases such as diabetes and auto-immune disorders during surgical procedures and increasing research activities to improve the therapeutics & diagnosis of chronic diseases. Additionally, the increasing demand for cell-based research activities and rising R&D investments will spur the global cell signaling industry in the future periods. Furthermore, the growing public-private funding for all cell-based research activities and increasing applicability in cancer research are expected to the remarkable growth of the cell signaling market. The rising growth of end-user industries and technological advancement in cell-based research instruments are expected to propel the demand for cell signaling over the coming years. Moreover, the rapidly expanding customer base, rise in the extensive R&D activities at the academic and industrial level, and increasing scope of signal transduction in drug discovery are fueling the demand for the cell signaling market. Additionally, the growing geriatric population and rising healthcare demands in the developing world propelling the growth of the cell signaling market across the globe.
Many private agencies and government bodies support and invest in cell-based research activities such as cell signaling, single-cell analysis, and stem cell research. Governments of various countries provide high grants to their academic institutions and research centers to promote cell-based Research, which can help manage chronic and infectious diseases and evaluate diagnostic and therapeutic applications of various types of cells. In addition, due to the availability of government support & encouragement and the growth of end-use industries are positively impacting the cell signaling market. However, the high cost of cell signaling systems and ethical issues related to stem cell signaling research are restraining the growth of the cell signaling market.
Academic cancer research labs support cancer research, leading to earlier detection, better treatments, and possibly even a cure. Cancer Institute and many labs funded by government organizations focus on signal transduction research to develop novel treatments for pancreatic cancer. Earlier, cancer treatments target any actively growing cell rather than just attacking the cancer cells. However, today researchers, an intense understanding of the signaling pathways that are hyperactive in cancer cells can lead to the development of treatments that target just not the cancer cells also spare the normal cells.
Based on the product, the global cell signaling market is segregated into consumables and instruments. The consumables segment is estimated to the highest growth over the analysis timeframe due to the rise in antibodies in molecular biology applications and disease diagnosis.
The instruments will grow significantly due to the rising cell signaling technology adoption in drug discovery and the rise in the utilization of cell signaling technology.
Based on the technology, the global cell signaling market is categorized into microscopy, western blotting, flow cytometry, immunohistochemistry, ELISA, mass spectrometry, and other technologies. The flow cytometry segment held for a significant market share in 2019 and will gain maximum market revenue by 2027. It is attributable to the widespread application of flow cytometry across the research industry. It provides high resolution at a single cell level & records multiple parameters and allows the researchers to trace the live moment.
The western blotting segment is poised to witness significant growth over the forecast period as it is used to differentiate the phosphorylated and un-phosphorylated proteins.
Based on the type, the global cell signaling market is categorized into endocrine signaling, paracrine signaling, juxtacrine signaling, autocrine signaling, and other signaling types. The endocrine signaling segment is held for a significant market share in 2019 and will gain maximum market revenue by 2027. It is attributable to producing hormones to communicate with remote target cells and gives a long-lasting response.
The paracrine signaling segment is poised to witness significant growth over the forecast period as it includes hormones that communicate to nearby or surrounding cells.
Based on the application, the global cell signaling market is classified into research applications and medical applications. The research applications are expected to be the highest revenue share for cell signaling during the forecast period. The segment’s growth is generally attributed to the growing incidence of chronic diseases, rising cell-based research activities, and technological advancement in cell biology instruments.
The medical application will witness a lucrative growth rate in the estimated period due to the adoption of cell signaling in pharmacologic mechanisms and to distinguish drug resistance patterns in cancerous cells.
The global cell signaling market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America is estimated to project considerable growth over 2020-2026. It is owing to advents in technology, the presence of leading industry players offering innovative products, and increasing healthcare expenditure.
The Asia Pacific will have a prominent share of the preimplantation genetic testing market by 2027. Due to the increasing adoption rates of cell signaling technologies, they were constantly improving healthcare infrastructure in the region and mounting health care expenditures in growing countries such as India and China.
Companies such as Thermo Fisher Scientific Inc., Merck KGaA, Beckman Becton Dickinson and Company, QIAGEN N.V., Bio-Rad Laboratories Inc, Cell Signaling Technology Inc, Promega Corporation, Coulter Inc, PerkinElmer Inc, Abcam plc and Miltenyi Biotec are the key players in the global cell signaling market.
By Product
By Technology
By Type
By Application
By Region
Analyst support
After evaluating your requirements and addressing your technical problems, the expert analyst will resolve your query directly.
Customer satisfaction
According to your needs, our expert team will assist you with the capabilities, services, and proper research needs to be required and customize the report accordingly.
Inimitable expertise
Our expert team will create unrivaled reviews to provide you with a deep understanding of the reports.
Assured quality
We have created a systematic way to determine standards and satisfy your expectations.
Instant delivery
Unlike others, we provide you a great deal of instant delivery in the form of PDF/PPT/Word Doc directly to your email address within 24 hours after receiving full payment.
Privacy policy
We understand the inkling of your privacy, we will never misuse your email address.
Custom research service
We are giving you an opportunity through which you can directly ask our expert analyst to customize an exclusive study of the report to serve your research needs.
Quality & accuracy
We provide you with the accurate quality of the customized study of an exclusive report according to your research need.
Data visualization
As the business world’s growing faster every day, we understand the value of data management. We will create the reports by keeping all the visual data sets and metrics in the charts.
Information security
We truly respect your privacy and promise to keep your personal and confidential information safe and secure.